NCT05513326

Brief Summary

The aim of this study is to determine the effectiveness of a 6-week specific rehabilitation program combining education and exercises on walking capacity in patients with LSS causing NC. The intervention group will receive standardized education and specific exercises while the control group will only receive standardized education. The program in both groups will last for 6 weeks with 4 evaluation timepoints (baseline, week 2, week 4 and post-intervention assessment). The primary outcomes will be walking capacity measured with the Self-Paced Walking Test and the secondary outcomes will be back and leg pain intensity, LSS-related disability, self-efficacy, level of physical activity, anxiety and depression, physical activity level, gait pattern characteristics, balance, and global perceived change.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 24, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

January 26, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

2.7 years

First QC Date

July 7, 2022

Last Update Submit

March 24, 2025

Conditions

Keywords

Spinal StenosisNeurogenic claudicationWalking capacityExercisesEducationgait pattern characteristics

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in walking capacity

    Walking capacity measure with the Self-Paced Walking Test (time)

    Baseline, week 2, week 4, week 6, week 12

Secondary Outcomes (10)

  • Change from baseline in leg and back pain intensity

    Baseline, week 2, week 4, week 6, week 12

  • Change from baseline in lumbar spinal stenosis related disabiltity

    Baseline, week 6, week 12

  • Changes from baseline in self-efficacy

    Baseline, week 6, week 12

  • Change from baseline in anxiety and depression

    Baseline, week 6, week 12

  • Change from baseline in physical activity level

    Baseline, week 6, week 12

  • +5 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Intervention group will received education and a specific rehabilitation program (exercises).

Other: Exercises and education

Control Group

OTHER

Control group will received education alone.

Other: Education alone

Interventions

Exercises: 3 training sessions per week that will last for 30 minutes. Sessions will start with 5 minutes of activation (walking on a treadmill or cycling). Then, participants will be asked to complete 5 exercises targeting lower limb strengthening (time: 18 minutes) followed by 2 exercises designed to improve balance and 3 stretching exercises for the lower limb (time: 7 minutes). Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.

Intervention Group

Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.

Control Group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being at least 50 years old
  • having a degenerative central LSS alone or in combination with other LSS types (e.g. foraminal, lateral) and/or a spondylolisthesis affecting one or multiple vertebral levels, confirmed by clinical history, physical examination and proper imaging
  • having NC associated with LSS
  • being able to speak and understand French
  • being willing to attend 3 intervention sessions per week
  • with a duration of signs and symptoms of at least 3 months
  • (7) being able to walk at least 20 meters without walking aid, but not being able to walk continuously for 30 minutes
  • being able to provide informed written consent.

You may not qualify if:

  • congenital LSS,
  • symptomatic osteoarthritis (hip or knee) causing limited walking capacity
  • neurological disease affecting walking capacity such as Parkinson
  • uncontrolled diabetes
  • heart failure
  • intermittent claudication of vascular origin
  • impaired cognitive capacity
  • back or lower extremities surgery in the past 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université du Québec à Trois-Rivières

Trois-Rivières, Quebec, G8Z 4M3, Canada

RECRUITING

Related Publications (1)

  • Houle M, Tetreau C, Chatillon CE, Marchand AA, Descarreaux M. Effectiveness of a 6-week specific rehabilitation program combining education and exercises on walking capacity in patients with lumbar spinal stenosis with neurogenic claudication: a randomized controlled clinical trial protocol. Trials. 2022 Dec 27;23(1):1046. doi: 10.1186/s13063-022-07011-3.

MeSH Terms

Conditions

Spinal StenosisMotor Activity

Interventions

ExerciseEducational Status

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaSocioeconomic FactorsPopulation Characteristics

Central Study Contacts

Mariève Houle, PhD(c)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 7, 2022

First Posted

August 24, 2022

Study Start

January 26, 2023

Primary Completion

September 30, 2025

Study Completion

December 31, 2025

Last Updated

March 28, 2025

Record last verified: 2025-03

Locations